Agenus Provides Update on Balstilimab Development

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/11/2026

1. ORCL
2. SPY
3. SPCX
4. USO
5. CHWY
6. NAVN
7. HUMA
8. NVDA
9. CRWV
10. CME

Go back to Agenus Provides Update on Balstilimab Development
AGENUS (NASDAQ: AGEN) Delayed: 3.39 +0.32 (10.42%)
Previous Close $3.07    52 Week High $7.49 
Open $3.09    52 Week Low $2.61 
Day High $3.42    P/E N/A 
Day Low $3.04    EPS $-1.10 
Volume 1,213,290